-
公开(公告)号:KR1020110093427A
公开(公告)日:2011-08-18
申请号:KR1020100013470
申请日:2010-02-12
Applicant: 서울대학교산학협력단
IPC: C07K16/18 , C12N15/63 , A61K39/395 , A61P35/00
CPC classification number: C07K16/3092
Abstract: PURPOSE: A single domain antibody or nanoscale antibody or nanoMAb is provided to diagnose cancer tissue which expresses MUC1 and to be used as an anti-tumor target therapeutic agent. CONSTITUTION: A single domain antibody for MUC1 contains a heavy chain variable region having: CDR1 selected from the group consisting of amino acids of sequence numbers 24-30; CDR2 selected from the group consisting of amino acids of sequence numbers 31-37; or CDR3 selected from the group consisting of amino acid of sequence number 38-44. The single domain antibody additionally contains a functional molecule. The functional molecule is chemicals, peptides, polypeptides, nucleic acids, carbohydrate, lipid, or inorganic particles.
Abstract translation: 目的:提供单域抗体或纳米抗体或纳米抗体,以诊断表达MUC1的癌组织,并用作抗肿瘤靶标治疗剂。 构成:用于MUC1的单结构域抗体包含重链可变区,其具有:CDR1,其选自序列号24-30的氨基酸; CDR2选自序列号31-37的氨基酸; 或选自序列号38-44的氨基酸的CDR3。 单结构域抗体另外含有功能性分子。 功能分子是化学物质,肽,多肽,核酸,碳水化合物,脂质或无机颗粒。